Alerts will be sent to your verified email
Verify EmailAARTIDRUGS
Aarti Drugs
|
Supriya Lifescience
|
IOL Chem & Pharma
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
APIs Production Capacity
|
45511.0 MTPA | n/a | n/a |
R&D as a % of Total Sales
|
1.93 % | n/a | 1.01 % |
Financials
|
|||
5 yr Average ROE
|
18.02 % | 23.4 % | 8.9 % |
5yr average Equity Multiplier
|
1.97 | 1.25 | 1.42 |
5yr Average Asset Turnover Ratio
|
1.09 | 0.68 | 0.99 |
5yr Avg Net Profit Margin
|
8.24 % | 25.52 % | 6.28 % |
Price to Book
|
3.5 | 5.87 | 2.09 |
P/E
|
25.37 | 32.85 | 33.53 |
5yr Avg Cash Conversion Cycle
|
79.88 Days | -10.96 Days | 37.81 Days |
Inventory Days
|
69.48 Days | 56.1 Days | 65.55 Days |
Days Receivable
|
111.3 Days | 57.43 Days | 86.45 Days |
Days Payable
|
97.75 Days | 113.66 Days | 100.1 Days |
5yr Average Interest Coverage Ratio
|
9.61 | 60.74 | 15.8 |
5yr Avg ROCE
|
21.16 % | 30.51 % | 12.63 % |
5yr Avg Operating Profit Margin
|
14.01 % | 36.15 % | 10.64 % |
5 yr average Debt to Equity
|
0.46 | 0.06 | 0.04 |
5yr CAGR Net Profit
|
-9.72 % | 8.75 % | -9.63 % |
5yr Average Return on Assets
|
9.12 % | 17.81 % | 6.27 % |
Shareholdings
|
|||
Promoter Holding
|
55.22 % | 68.3 % | 52.62 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
-4.76 % | 0.06 % | 8.93 % |
Change in Mutual Fund Holding (3 Yrs)
|
7.17 % | -2.44 % | 0.0 |
Aarti Drugs
|
Supriya Lifescience
|
IOL Chem & Pharma
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|